Supported by an educational grant from Neurocrine Biosciences, Inc.

Videos

TD Caregiver and Patient Advocate Interview

All Videos

Differential Diagnosis of Tardive Dyskinesia and Drug-Induced Parkinsonism
Join Psych Congress Scientific Director Craig Chepke, MD, DFAPA as he reviews how to appropriately differentiate between movement disorders.
Helping Patients Navigate Psychopharmacological and Social Challenges in Tardive Dyskinesia
Kevin Williams, MS, MPAS, PA-C, details how clinicians can more closely incorporate caregivers into patient treatment plans, as well as how to navigate a conversation with a patient who has stopped taking their medications for tardive dyskinesia.
Clinical Pearls to Enhance Tardive Dyskinesia Treatment
Amber Hoberg, MSN, APRN, PMHNP-BC, of Med Management Associates, offers clinical pearls that clinicians can implement to optimize their tardive dyskinesia care.
Activation Maneuvers' Can Help Identify Mild to Moderate TD
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses how providers can reassess treatment plans should tardive dyskinesia (TD) develop and what practices can be incorporated to identify mild, moderate, and severe TD.
Patient-Centered Tools to Implement When Screening for Tardive Dyskinesia
Amber Hoberg, MSN, APRN, PMHNP-BC, discussed why tardive dyskinesia (TD) continues to be underdiagnosed and what screening tools should be used to identify and diagnose the disorder with patient needs in mind.